[ad_1]
According to the written statement of the Ministry of Health, the Covid-19 vaccine of Chinese origin, which began Phase 3 studies in our country on September 15, is also beginning to be applied to volunteer citizens after health workers.
Citizens aged 18 to 59 who have not previously had Covid-19 can volunteer at https://covid19asi.calismasi.info or by calling 0850 811 18 80.
KORONA VACCINE APPLICATIONS CONTINUE IN 25 CENTERS IN 12 CITIES
Applications of the Covidien-19 vaccine continue at 25 centers in 12 cities in Turkey. The vaccine, which was first introduced to high-risk healthcare workers, has been administered to 726 volunteer healthcare workers to date and 1,237 doses of vaccine have been administered. Since the security data of the applications in the group of health professionals was evaluated positively, the applications were also opened to normal and risky citizens.
Interim evaluation reports are prepared for every 500 volunteers in the ongoing stages of vaccination. According to the interim safety report prepared with 518 people on November 6, the vaccine was determined to have no significant side effects. The most common side effects were fatigue (7.5%), headache (3.5%), muscle pain (3%), fever (3%), and pain at the injection site (2.5%) . The independent data monitoring committee stated that it had no reservations about the safety of the vaccine in its evaluation of the interim safety report with the available data.
Vaccination; It continues in two stages as high-risk healthcare workers and normal-risk volunteers. It is planned to apply the Covid-19 vaccine in 12 thousand 450 volunteers in total.
In the vaccine study, some of the volunteers receive the actual vaccine and the other part receives a placebo. This method is determined randomly by the computer program and the research team does not know what was done to which volunteer.
In trials to be conducted with citizen volunteers, 2 out of 3 people will receive a real vaccine. In this way, the difference in effect between the real vaccine and the non-vaccine will be revealed. At the end of the study, all volunteers in the placebo group will be invited to return to the centers and will be given the vaccine.
PEOPLE 18 TO 59 YEARS OLD WHO HAVE NOT BEEN COVID-19 BEFORE MAY VOLUNTEER
The Chinese-origin vaccine Covid-19, which began Phase 3 studies in our country on September 15, is also beginning to be applied to volunteer citizens after health professionals. Citizens aged 18 to 59 who have not previously had Covid-19 can volunteer at https://covid19asi.calismasi.info or by calling 0850 811 18 80.
Applications of the Covidien-19 vaccine continue at 25 centers in 12 cities in Turkey. The vaccine, which was first introduced to high-risk healthcare workers, has so far been administered to 726 volunteer healthcare workers and 1,237 doses of the vaccine have been administered. Since the security data of the applications in the group of healthcare professionals was evaluated positively, the applications were opened to normal and risky citizens.
Interim evaluation reports are prepared for every 500 volunteers in the ongoing stages of vaccination. According to the interim safety report prepared with 518 people on November 6, the vaccine was determined to have no significant side effects. The most common side effects were fatigue (7.5%), headache (3.5%), muscle pain (3%), fever (3%), and pain at the injection site (2.5%) . The independent data monitoring committee reported that it had no reservations about the safety of the vaccine in its evaluation of the interim safety report with the available data.
Vaccination; It continues in two stages as high-risk healthcare workers and normal-risk volunteers. It is planned to apply the Covid-19 vaccine in 12 thousand 450 volunteers in total.
In the vaccine study, some of the volunteers receive the actual vaccine and the other part receives a placebo. This method is determined randomly by the computer program and the research team does not know what was done to each volunteer.
In the trials to be conducted with volunteer citizens, 2 out of 3 people will receive a real vaccine. In this way, the difference in effect between the real vaccine and the non-vaccine will be revealed. At the end of the study, all volunteers in the placebo group will be invited to return to the centers and will be given the vaccine.
